istock-183060916

oonal / iStockphoto.com

19 February 2018Americas

Roche to make $1.9bn acquisition

Switzerland-based Roche has revealed plans to acquire a healthcare technology company for $1.9 billion.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Eli Lilly to buy immuno-oncology firm in $1.6bn deal

11 May 2018 Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.

Roche to pay $2.4bn for remainder of Foundation Medicine

20 June 2018 Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.

Roche to make $4.3bn gene therapy acquisition

25 February 2019 Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.

More on this story

Eli Lilly to buy immuno-oncology firm in $1.6bn deal

11 May 2018 Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.

Roche to pay $2.4bn for remainder of Foundation Medicine

20 June 2018 Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.

Roche to make $4.3bn gene therapy acquisition

25 February 2019 Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.

More on this story

Eli Lilly to buy immuno-oncology firm in $1.6bn deal

11 May 2018 Eli Lilly has set its sights on Armo BioSciences in a bid to strengthen its immuno-oncology programme.

Roche to pay $2.4bn for remainder of Foundation Medicine

20 June 2018 Switzerland-based Roche has agreed to pay $2.4 billion to acquire the remainder of Foundation Medicine, a molecular and genomic analysis company headquartered in Cambridge, Massachusetts.

Roche to make $4.3bn gene therapy acquisition

25 February 2019 Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Attorney v examiner: Navigating patenting's AI tools ‘arms race’

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool